000300190 001__ 300190
000300190 005__ 20250411082136.0
000300190 0247_ $$2doi$$a10.1016/j.gassur.2025.102035
000300190 0247_ $$2pmid$$apmid:40154837
000300190 0247_ $$2ISSN$$a1091-255X
000300190 0247_ $$2ISSN$$a1873-4626
000300190 037__ $$aDKFZ-2025-00667
000300190 041__ $$aEnglish
000300190 082__ $$a610
000300190 1001_ $$aBetzler, Alexander$$b0
000300190 245__ $$aLong-term diuretic medication is an independent predictor of posthepatectomy liver failure 
000300190 260__ $$a[Amsterdam]$$bElsevier$$c2025
000300190 3367_ $$2DRIVER$$aarticle
000300190 3367_ $$2DataCite$$aOutput Types/Journal article
000300190 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744352430_27546
000300190 3367_ $$2BibTeX$$aARTICLE
000300190 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300190 3367_ $$00$$2EndNote$$aJournal Article
000300190 500__ $$a#EA:B440# / 2025 Mar 26;29(5):102035
000300190 520__ $$aPosthepatectomy liver failure (PHLF) is the most fatal complication following liver resection, particularly, in patients with comorbidities. This study aimed to assess the impact of long-term medication on PHLF incidence after open liver resections.A retrospective analysis of 682 patients who underwent elective open hepatectomies between 2008 and 2015 at two academic centers was performed. Preoperative, intraoperative, and postoperative data were collected, including long-term medication. Risk factors for the development of PHLF and other postoperative complications were evaluated using univariate and multivariable logistic regression analyses.PHLF occurred in 11.9% (n=81) of patients, with a higher incidence in those taking diuretics as long-term medication (17.7% vs. 5.3%, P < 0.001). Diuretic use was identified as a strong independent risk factor for PHLF (OR 3.8, 95%CI 2.1 - 7.0, P < 0.001), alongside liver cirrhosis (OR 3.8, 95%CI 1.9 - 7.6, P < 0.001), primary liver malignancies (OR 3.8, 95%CI 1.6 - 9.3, P < 0.001), major hepatectomies (OR 3.1, 95%CI 1.7 - 5.7, P < 0.001) and long operating time (OR 4.2, 95% CI 2.4 - 7.2, P < 0.001). Patients with long-term diuretic intake were older, had higher BMIs, and more comorbidities, including liver cirrhosis.Long-term diuretic use is associated with a significantly increased risk of PHLF after open hepatectomy.
000300190 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000300190 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000300190 650_7 $$2Other$$aISGLS
000300190 650_7 $$2Other$$acomedication
000300190 650_7 $$2Other$$acomorbidity
000300190 650_7 $$2Other$$ahepatectomy
000300190 650_7 $$2Other$$amultimorbidity
000300190 7001_ $$0P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07$$aBetzler, Johanna$$b1$$eFirst author$$udkfz
000300190 7001_ $$aBogner, Andreas$$b2
000300190 7001_ $$aWalther, Elene$$b3
000300190 7001_ $$aRahbari, Mohammad$$b4
000300190 7001_ $$aReissfelder, Christoph$$b5
000300190 7001_ $$aRiediger, Carina$$b6
000300190 7001_ $$aWeitz, Jürgen$$b7
000300190 7001_ $$aRahbari, Nuh N$$b8
000300190 7001_ $$aBirgin, Emrullah$$b9
000300190 773__ $$0PERI:(DE-600)2057634-1$$a10.1016/j.gassur.2025.102035$$gp. 102035 -$$n5$$p102035$$tJournal of gastrointestinal surgery$$v29$$x1091-255X$$y2025
000300190 909CO $$ooai:inrepo02.dkfz.de:300190$$pVDB
000300190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79e2e48100b40ab9f33fb2cb119d6f07$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000300190 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000300190 9141_ $$y2025
000300190 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000300190 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000300190 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ GASTROINTEST SURG : 2022$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000300190 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000300190 9201_ $$0I:(DE-He78)B440-20160331$$kB440$$lNWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle$$x0
000300190 9200_ $$0I:(DE-He78)B440-20160331$$kB440$$lNWG-KKE Translationale Gastrointestinale Onkologie und präklinische Modelle$$x0
000300190 980__ $$ajournal
000300190 980__ $$aVDB
000300190 980__ $$aI:(DE-He78)B440-20160331
000300190 980__ $$aUNRESTRICTED